37822160|t|FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.
37822160|a|Mesenchymal glioblastoma (GBM) is highly resistant to radio-and chemotherapy and correlates with worse survival outcomes in GBM patients; however, the underlying mechanism determining the mesenchymal phenotype remains largely unclear. Herein, it is revealed that FBXO7, a substrate-recognition component of the SCF complex implicated in the pathogenesis of Parkinson's disease, confers mesenchymal properties and chemoresistance in GBM by controlling Rbfox2-mediated alternative splicing. Specifically, FBXO7 ubiquitinates Rbfox2 Lys249 through K63-linked ubiquitin chains upon arginine dimethylation at Arg341 and Arg441 by PRMT5, leading to Rbfox2 stabilization. FBXO7 controls Rbfox2-mediated splicing of mesenchymal genes, including FoxM1, Mta1, and Postn. FBXO7-induced exon Va inclusion of FoxM1 promotes FoxM1 phosphorylation by MEK1 and nuclear translocation, thereby upregulates CD44, CD9, and ID1 levels, resulting in GBM stem cell self-renewal and mesenchymal transformation. Moreover, FBXO7 is stabilized by temozolomide, and FBXO7 depletion sensitizes tumor xenografts in mice to chemotherapy. The findings demonstrate that the FBXO7-Rbfox2 axis-mediated splicing contributes to mesenchymal transformation and tumorigenesis, and targeting FBXO7 represents a potential strategy for GBM treatment.
37822160	0	5	FBXO7	Gene	25793
37822160	60	72	Glioblastoma	Disease	MESH:D005909
37822160	88	94	Rbfox2	Gene	23543
37822160	138	150	glioblastoma	Disease	MESH:D005909
37822160	152	155	GBM	Disease	MESH:D005909
37822160	250	253	GBM	Disease	MESH:D005909
37822160	389	394	FBXO7	Gene	25793
37822160	437	440	SCF	Gene	4254
37822160	483	502	Parkinson's disease	Disease	MESH:D010300
37822160	558	561	GBM	Disease	MESH:D005909
37822160	577	583	Rbfox2	Gene	23543
37822160	629	634	FBXO7	Gene	25793
37822160	649	655	Rbfox2	Gene	23543
37822160	751	756	PRMT5	Gene	10419
37822160	769	775	Rbfox2	Gene	23543
37822160	791	796	FBXO7	Gene	25793
37822160	806	812	Rbfox2	Gene	93686
37822160	863	868	FoxM1	Gene	14235
37822160	870	874	Mta1	Gene	9112
37822160	880	885	Postn	Gene	10631
37822160	887	892	FBXO7	Gene	25793
37822160	922	927	FoxM1	Gene	2305
37822160	937	942	FoxM1	Gene	14235
37822160	962	966	MEK1	Gene	5604
37822160	1014	1018	CD44	Gene	12505
37822160	1020	1023	CD9	Gene	12527
37822160	1029	1032	ID1	Gene	15901
37822160	1054	1057	GBM	Disease	MESH:D005909
37822160	1123	1128	FBXO7	Gene	25793
37822160	1146	1158	temozolomide	Chemical	MESH:D000077204
37822160	1164	1169	FBXO7	Gene	69754
37822160	1191	1196	tumor	Disease	MESH:D009369
37822160	1267	1272	FBXO7	Gene	25793
37822160	1273	1279	Rbfox2	Gene	23543
37822160	1349	1362	tumorigenesis	Disease	MESH:D063646
37822160	1378	1383	FBXO7	Gene	25793
37822160	1420	1423	GBM	Disease	MESH:D005909
37822160	Positive_Correlation	12527	25793
37822160	Association	10631	25793
37822160	Association	25793	5604
37822160	Association	14235	93686
37822160	Association	MESH:D005909	23543
37822160	Association	MESH:D000077204	25793
37822160	Association	MESH:D005909	2305
37822160	Association	25793	9112
37822160	Association	23543	25793
37822160	Association	14235	25793
37822160	Positive_Correlation	15901	25793
37822160	Association	MESH:D010300	25793
37822160	Association	MESH:D005909	25793
37822160	Positive_Correlation	2305	25793
37822160	Association	10631	93686
37822160	Association	14235	5604
37822160	Association	MESH:D063646	23543
37822160	Association	MESH:D009369	69754
37822160	Association	25793	93686
37822160	Association	9112	93686
37822160	Association	MESH:D063646	25793
37822160	Positive_Correlation	12505	25793
37822160	Association	25793	4254

